These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 39047262)

  • 21. Possible role of polypeptide-chlorogenic acid interaction in the physicochemical and sensory characteristics of quinoa-modified coffee beverage.
    Ji X; Wang L; Zhao J; Jiang J
    Food Chem; 2023 Nov; 425():136359. PubMed ID: 37244236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RSPO2-LGR5 signaling has tumour-suppressive activity in colorectal cancer.
    Wu C; Qiu S; Lu L; Zou J; Li WF; Wang O; Zhao H; Wang H; Tang J; Chen L; Xu T; Sun Z; Liao W; Luo G; Lu X
    Nat Commun; 2014; 5():3149. PubMed ID: 24476626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supplementation of quinoa peptides alleviates colorectal cancer and restores gut microbiota in AOM/DSS-treated mice.
    Fan X; Guo H; Teng C; Yang X; Qin P; Richel A; Zhang L; Blecker C; Ren G
    Food Chem; 2023 May; 408():135196. PubMed ID: 36535178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chlorquinaldol targets the β-catenin and T-cell factor 4 complex and exerts anti-colorectal cancer activity.
    Wang L; Deng K; Gong L; Zhou L; Sayed S; Li H; Sun Q; Su Z; Wang Z; Liu S; Zhu H; Song J; Lu D
    Pharmacol Res; 2020 Sep; 159():104955. PubMed ID: 32485279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High pressure-assisted enzymatic hydrolysis potentiates the production of quinoa protein hydrolysates with antioxidant and ACE-inhibitory activities.
    de Carvalho Oliveira L; Martinez-Villaluenga C; Frias J; Elena Cartea M; Francisco M; Cristianini M; Peñas E
    Food Chem; 2024 Jul; 447():138887. PubMed ID: 38492299
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LGR5 promotes survival in human colorectal adenoma cells and is upregulated by PGE2: implications for targeting adenoma stem cells with NSAIDs.
    Al-Kharusi MR; Smartt HJ; Greenhough A; Collard TJ; Emery ED; Williams AC; Paraskeva C
    Carcinogenesis; 2013 May; 34(5):1150-7. PubMed ID: 23349017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis.
    Kang XL; He LR; Chen YL; Wang SB
    World J Gastroenterol; 2020 Nov; 26(43):6853-6866. PubMed ID: 33268966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploration on bioactive properties of quinoa protein hydrolysate and peptides: a review.
    Guo H; Hao Y; Yang X; Ren G; Richel A
    Crit Rev Food Sci Nutr; 2023; 63(16):2896-2909. PubMed ID: 34581209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
    Stanisavljević L; Myklebust MP; Leh S; Dahl O
    Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LGR5, a novel functional glioma stem cell marker, promotes EMT by activating the Wnt/β-catenin pathway and predicts poor survival of glioma patients.
    Zhang J; Cai H; Sun L; Zhan P; Chen M; Zhang F; Ran Y; Wan J
    J Exp Clin Cancer Res; 2018 Sep; 37(1):225. PubMed ID: 30208924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leucine-rich repeat-containing G-protein-coupled receptor 5 is associated with invasion, metastasis, and could be a potential therapeutic target in human gastric cancer.
    Xi HQ; Cai AZ; Wu XS; Cui JX; Shen WS; Bian SB; Wang N; Li JY; Lu CR; Song Z; Wei B; Chen L
    Br J Cancer; 2014 Apr; 110(8):2011-20. PubMed ID: 24594994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structures of Wnt-antagonist ZNRF3 and its complex with R-spondin 1 and implications for signaling.
    Peng WC; de Lau W; Madoori PK; Forneris F; Granneman JC; Clevers H; Gros P
    PLoS One; 2013; 8(12):e83110. PubMed ID: 24349440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leucine-rich repeat-containing G protein-coupled receptor 5 marks different cancer stem cell compartments in human Caco-2 and LoVo colon cancer lines.
    Alharbi SA; Ovchinnikov DA; Wolvetang E
    World J Gastroenterol; 2021 Apr; 27(15):1578-1594. PubMed ID: 33958845
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhancing precision in colorectal cancer surgery: development of an LGR5-targeting RSPO1 peptide mimetic as a contrast agent for intraoperative fluorescence molecular imaging.
    Parasido E; Ribeiro P; Chingle RM; Rohwetter T; Gupta N; Avetian G; Bladelli E; Pierobon M; Chen Y; Tang Q; Schnermann M; Rodriguez O; Robbins D; Burke TR; Albanese C; Ihemelandu C
    Cell Cycle; 2024 Jul; ():1-12. PubMed ID: 38984667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LGR5 is a negative regulator of tumourigenicity, antagonizes Wnt signalling and regulates cell adhesion in colorectal cancer cell lines.
    Walker F; Zhang HH; Odorizzi A; Burgess AW
    PLoS One; 2011; 6(7):e22733. PubMed ID: 21829496
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LGR5 promotes cancer stem cell traits and chemoresistance in cervical cancer.
    Cao HZ; Liu XF; Yang WT; Chen Q; Zheng PS
    Cell Death Dis; 2017 Sep; 8(9):e3039. PubMed ID: 28880275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of LGR5 expression in poorly differentiated colorectal carcinoma with mismatch repair protein deficiency.
    Nakajima T; Uehara T; Iwaya M; Kobayashi Y; Maruyama Y; Ota H
    BMC Cancer; 2020 Apr; 20(1):319. PubMed ID: 32293346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FOXD1 promotes chemotherapy resistance by enhancing cell stemness in colorectal cancer through β‑catenin nuclear localization.
    Feng WQ; Zhang YC; Gao H; Li WC; Miao YM; Xu ZF; Xu ZQ; Zhao JK; Zheng MH; Zong YP; Lu AG
    Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37203394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting LGR5 in Colorectal Cancer: therapeutic gold or too plastic?
    Morgan RG; Mortensson E; Williams AC
    Br J Cancer; 2018 May; 118(11):1410-1418. PubMed ID: 29844449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of LGR5 through Therapy-induced Downregulation or Gene Ablation Is Associated with Resistance and Enhanced MET-STAT3 Signaling in Colorectal Cancer Cells.
    Posey TA; Jacob J; Parkhurst A; Subramanian S; Francisco LE; Liang Z; Carmon KS
    Mol Cancer Ther; 2023 May; 22(5):667-678. PubMed ID: 36921315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.